Related Experiment Video
Updated: Sep 23, 2025

08:14
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells
Published on: December 3, 2015
7.7K
ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage
Wuming Gong1, Satyabrata Das1, Javier E Sierra-Pagan1
1Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Nature Cell Biology
|May 13, 2022
Summary
ETV2 acts as a pioneer factor, relaxing chromatin to promote endothelial development. This discovery offers a new platform for treating cardiovascular diseases and solid tumors.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- The vasculature is crucial for oxygen delivery and relevant to ischaemic diseases, regeneration, and tumor growth.
- ETV2 (Ets variant 2) was previously identified as essential for cardiac, endothelial, and hematopoietic lineage development.
Purpose of the Study:
- To investigate the role of ETV2 as a pioneer transcription factor in regulating endothelial development.
- To elucidate the molecular mechanisms by which ETV2 influences chromatin structure and gene expression.
Main Methods:
- Utilized engineered embryonic stem cell differentiation and reprogramming models.
- Employed multi-omics techniques to analyze molecular changes.
- Investigated the binding of ETV2 to nucleosomal DNA and its recruitment of BRG1.
Main Results:
- ETV2 functions as a pioneer factor, relaxing closed chromatin.
- ETV2 binds nucleosomal DNA and recruits BRG1, a component of the SWI/SNF chromatin remodeling complex.
- BRG1-mediated chromatin remodeling at endothelial genes maintains an open configuration and increases H3K27ac deposition.
Conclusions:
- ETV2 plays a critical role in endothelial development by acting as a pioneer factor that remodels chromatin.
- The findings provide a mechanistic understanding of ETV2's function in regulating endothelial gene expression.
- These results establish a foundation for developing novel therapeutics for cardiovascular diseases and solid tumors.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Mechanism of Angiogenesis
6.0K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Lineage Commitment
3.3K
Commitment is the process whereby stem cells:
3.3K

